A team of investigators sought to determine the ability of the Cytosponge to detect the persistence of Barrett esophagus following eradication therapy.
Budesonide oral suspension improved histologic, endoscopic, and both histologic and symptomatic outcomes in children with eosinophilic esophagitis compared with placebo.
A team of investigators conducted a prospective, single-center, observational study at the Cleveland Clinic to determine the safety and feasibility of IT-knife tunneling and C-shaped incision endoscopic submucosal dissection of the esophagus.
Investigators performed a cross-sectional study to assess reflux esophagitis in patients having undergone successful eradication of Helicobacter pylori infection.
Researchers aimed to describe the impact of the COVID-19 pandemic on the diagnosis of Barrett esophagus and esophagogastric cancer in Northern Ireland.
A new consensus paper provides 40 statements on many factors of GERD, including clinical features, endoscopy, physiologic investigations, lifestyle interventions, optimizing acid-suppressive therapy, adjunctive medical therapy, and surgical and interventional management.
Study examines whether every-second-day administration of vonoprazan reduces symptoms more effectively than proton pump inhibitors in patients with erosive GERD.
Researchers evaluated the efficacy, safety, and feasibility of concomitant transoral incisionless fundoplication to reduce symptoms of heartburn, regurgitation, and reflux.
A team of investigators conducted a retrospective review to assess the efficacy of magnetic sphincter augmentation for gastroesophageal reflux disease.
A team of investigators sought to determine the prevalence of proton pump inhibitor-partial response gastroesophageal reflux disease in patients with systemic sclerosis.
A team of investigators sought to assess the prevalence of Barrett esophagus in a large cohort of women with systemic sclerosis or scleroderma who underwent esophagogastroduodenoscopy.
Researchers sought to determine the effects of providing early interdisciplinary care on overall survival, progression-free survival, and adverse events in previously untreated patients with esophagogastric cancer.
Given the lack of effective tools available for observing EGD, researchers sought to develop an AI-assisted EGD system to automatically monitor the entire stomach in real time and maintain a record of the procedure time.
Results presented at the European Society for Medical Oncology Virtual Congress 2020showed significant improvements in the primary endpoints for the pembrolizumab group.